Lantus and Sumatriptan succinate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Sumatriptan succinate (sumatriptan succinate). Common drug interactions include blood glucose increased among females and blood glucose increased among males.
The phase IV clinical study analyzes what interactions people have when they take Lantus and Sumatriptan succinate. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
What is Sumatriptan succinate?
Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.
55 people who take Lantus and Sumatriptan succinate together, and have interactions are studied.

What are the common drug interactions of Lantus and Sumatriptan Succinate, by gender? *:
female:
- Blood glucose increased
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Hyperglycaemia (high blood sugar)
- Weight decreased
- Renal failure (kidney dysfunction)
- Death
- Pneumonia
- Abdominal pain
- Chronic kidney disease
- Drug hypersensitivity
male:
- Blood glucose increased
- Nonspecific reaction (unspecified reaction)
- Chronic kidney disease
- Diarrhoea
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Kidney infection
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal injury (kidney injury)
- Squamous cell carcinoma (a cancer of a kind of epithelial cell)
- Weight decreased
What are the common drug interactions of Lantus and Sumatriptan Succinate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Overdose
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Weight decreased
30-39:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
40-49:
- Interstitial lung disease
- Acute respiratory distress syndrome
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Cardiac failure congestive
- Chest discomfort
- Chest pain
- Chronic kidney disease
- Coma (state of unconsciousness lasting more than six hours)
- Drug clearance decreased
- Drug hypersensitivity
50-59:
- Blood glucose increased
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Hyperglycaemia (high blood sugar)
- Death
- Abdominal pain
- Pruritus (severe itching of the skin)
- Renal failure (kidney dysfunction)
- Diarrhoea
- Sinusitis (inflammation of sinus)
- Squamous cell carcinoma (a cancer of a kind of epithelial cell)
60+:
- Nonspecific reaction (unspecified reaction)
- Blood glucose increased
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal injury (kidney injury)
- Biliary obstruction
- Decreased appetite
- Diarrhoea
- Haemorrhage (bleeding)
- Increased appetite
What are the existing conditions these people have? *
- Parkinson's Disease: 7 people, 12.73%
- Pain: 6 people, 10.91%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.09%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 7.27%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.27%
- Immunodeficiency Common Variable: 3 people, 5.45%
* Approximation only. Some reports may have incomplete information.
Do you take Lantus and Sumatriptan succinate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lantus (191,782 reports)
- Sumatriptan succinate (9,731 reports)
Browse all drug interactions of Lantus and Sumatriptan succinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sumatriptan succinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sumatriptan succinate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin glargine recombinant and sumatriptan succinate (the active ingredients of Lantus and Sumatriptan succinate, respectively), and Lantus and Sumatriptan succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Felodipine cause Thrombocytosis? - 2 seconds ago
- How effective is Carbamazepine for Trigeminal Neuralgia? - 4 seconds ago
- Drug interactions of Amlodipine and Exidine - 4 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Doxazosin Mesylate - 8 seconds ago
- Drug interactions of Irbesartan and Potassium Iodide - 8 seconds ago
- Acetazolamide vs. Gabapentin, side effect and effectiveness comparison - 9 seconds ago
- Could Rabeprazole cause Influenza Like Illness? - 11 seconds ago
- Drug interactions of Atrovent and Albuterol Sulfate - 15 seconds ago
- Could Intelence cause Hair Loss? - 15 seconds ago
- Could Esomeprazole Sodium cause Rash Macular? - 16 seconds ago